Evaluation of the effects of combined consumption of test foods containing plant-derived bioactive substances on the biomarker in blood

Not Applicable

• Conditions: Healthy subjects

• Registration Number: JPRN-UMIN000048976
• Lead Sponsor: KAGOME CO., LTD.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-09-21
• Study Completion: 2022-12-02
• Last Update Posted: 1 April 2024

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Not provided

Exclusion Criteria

1) Those who have factors other than dietary habits that greatly affect blood biomarker concentration (Habitual drinker or smoker, those who have an infectious disease within 1 month of the start of the study, those who take antibiotics within 1 month of the start of the study, those who have chronic digestive disorders) 2) Those who have factors other than blood biomarker concentration that greatly affect appetite (Those who eat less than two meals a day on some days, those who are undergoing hormone therapy [including steroid]) 3) Those who may have adverse events when collecting blood (those who are sensitive to alcohol to the extent that alcohol disinfection is difficult, those who have skin diseases on their fingers, Those who with severe anemia) 4) Those who are unable to draw the required amount of blood (100 microL) at the screening 5) Those who may develop allergies due to ingestion of the test foods 6) Subjects who regularly use medicines, health foods, and supplements (Except for those who can stop taking health foods and supplements approximately one week prior to the start of the study) 7) Those who habitually consume (at least twice a week) foods containing the same active ingredients as the test foods and beverages (Except for those who can reduce the intake of these foods to less than twice a week for both about 1 week prior to the start of the study) 8) Those who participated in other human studies within 1 month of the start of this study 9) Pregnant or lactating women, women who expect to be pregnant during this study or may be pregnant 10) Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood biomarker concentrations

Secondary Outcome Measures

Name	Time	Method
Appetite score, nutrient intake